JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2019, 68(3):91-94 | DOI: 10.36290/csf.2019.011

Theory and practice of pharmacopoeial control of quality of drugs and excipients IX. The problem of tolerance limits for the content of active substances and excipients in the European Pharmacopoeia (Ph. Eur.)

Jan Šubert, Jozef Kolář1,*
1 Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav aplikované farmacie, Brno

Content tolerance limits should respect the acceptable variation in the content of the active substance or excipient from its production and the variability of the results of the analytical procedure prescribed to determine the content by the appropriate pharmacopoeia. This usually prevails in the active substances and excipients. They should be derived statistically based on the precision of the prescribed analytical method determined by the interlaboratory test. Calculations from published precision characteristics show that some tolerance intervals for the active substance content are probably too narrow in Ph. Eur. This can lead to erroneous decisions about their quality.

Keywords: Ph. Eur.; determination of active substance content; interlaboratory study; statistical tolerance limits

Received: May 5, 2019; Accepted: May 27, 2019; Published: March 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šubert J, Kolář J. Theory and practice of pharmacopoeial control of quality of drugs and excipients IX. The problem of tolerance limits for the content of active substances and excipients in the European Pharmacopoeia (Ph. Eur.). Čes. slov. farm. 2019;68(3):91-94. doi: 10.36290/csf.2019.011.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Reimers F. The Basic Principles for Pharmacopoeial Tests. Copenhagen, London: Ejnar Munksgaard, Heinemann Medical Books 1956; 76.
    2. Fürst W. Zur Bedeutung der Standardabweichung für die Aufstellung von Arzneibuchmonografien. Zbl. Pharm. 1973; 112, 701-710.
    3. Diding N., Johansson S., Ohlson B., Öhrner B. Anforderungen an Präzision, Genauigkeit und Spezifität von Gehaltsbestimmungen unter Verwendung von Standards. Zbl. Pharm. 1981; 120, 779-788.
    4. Československý lékopis, 3. vydání, svazek II. Praha: Avicenum 1970; 463-464.
    5. Sachs L. Angewandte Statistik. 4. Aufl. Berlin, Heidelberg, New York: Springer-Verlag 1974.
    6. Eckschlager K., Horsák I., Kodejš Z. Vyhodnocování analytických výsledků a metod. Praha: SNTL 1980.
    7. Youden W. J., Steiner E. H. Statistical Manual of the AOAC. Washington: Association of Official Analytical Chemists 1975.
    8. Šubert J., Grolichová L. Ke kvantitativnímu hodnocení léčiv v ČsL 3. XVI. Stanovení obsahu krystalického dusičnanu stříbrného - kruhový test. Farm. Obzor 1986; 55, 25-28.
    9. Československý lékopis, 4. vydání, svazek II. Praha: Avicenum 1987; 101.
    10. European Pharmacopoeia Online 9.5 (http://online6.edqm.eu/ep905/ Accessed 05-02-2019).
    11. Daas A. G. J., Miller J. H. McB. Content limits in the European Pharmacopoeia (Part 1). Pharmeuropa 1997; 9, 148-156.
    12. Daas A. G. J., Miller J. H. McB. Content limits in the European Pharmacopoeia (Part 2). Pharmeuropa 1998; 10, 137-146.
    13. Margosis M., Horwitz W., Albert R. Performance characteristics of methods of analysis used for regulatory purposes. I. Drug dosage forms. F. Gravimetric and titrimetric methods. J. Assoc. Off. Anal. Chem. 1988; 71, 619-635. Go to original source...
    14. Horwitz W., Albert R. H. Performance characteristics of methods of analysis used for regulatory purposes. I. Drug dosage forms. D. High pressure liquid chromatographic methods. J. Assoc. Off. Anal. Chem. 1985; 68, 191-198. Go to original source...
    15. Jílek M. Statistické toleranční meze. Praha: SNTL 1988.
    16. Jílek M. Počet měření a odhad přesnosti chemických analýz. Chem. Listy 1981; 75, 937-946.
    17. Dong X., Tsong Y., Shen M., Zhong J. Using tolerance intervals for assessment of pharmaceutical quality. J. Biopharm. Stat. 2015; 25, 317-327. doi:10.1080/10543406.2014.972512. Go to original source... Go to PubMed...
    18. De Beer J. O., De Spiegeleer B. M. J., Hoogmartens J., Samson I., Massart D. L., Moors M. Relationship between content limits and assay methods: an interlaboratory statistical evaluation. Analyst 1992; 117, 933-940. Go to original source...
    19. Šubert J., Grolichová L. Ke kvantitativnímu hodnocení léčiv v ČsL 3/ČsL 4. XX. Stanovení obsahu trometamolu a benzoové kyseliny - kruhový test. Českoslov. Farm. 1988; 37, 133-137.
    20. Ebel S. Assay content limits in the pharmacopoeia. Pharmeuropa 1997; 9, 143-147.
    21. van Rompay J. How to construct and use the specifications of chemical substances. Pharmeuropa 1997; 9, 135-139.
    22. van de Vaart F. J. Content limits - setting and use. Pharmeuropa 1997; 9, 140-143.

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.